After watching this webinar, participants will be able to:

• Provide an overview of present screening for hyperglycaemia and management of patients with type 2 diabetes and atherosclerotic vascular disease;
• Understand the importance of multifactorial risk factor management; and
• Review available evidence behind novel glucose-lowering drugs with cardioprotective capacity and when to choose different types of such treatment.